BioTE is a medical company that provides bioidentical hormone pellet therapy.
BioTE has raised $25.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2023.
BioTE is headquartered in Irving, United States.
BioTE is a medical company that provides bioidentical hormone pellet therapy.
BioTE is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BioTE — Funding & Investors." VCBacked, January 1, 2023, https://www.vcbacked.co/company/biote. Accessed August 13, 2026.
VCBacked. (2023). BioTE — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/biote
{{cite web |title=BioTE — Funding & Investors |url=https://www.vcbacked.co/company/biote |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated